Welcome to LookChem.com Sign In|Join Free

CAS

  • or

254878-95-0

Post Buying Request

254878-95-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

254878-95-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 254878-95-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,5,4,8,7 and 8 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 254878-95:
(8*2)+(7*5)+(6*4)+(5*8)+(4*7)+(3*8)+(2*9)+(1*5)=190
190 % 10 = 0
So 254878-95-0 is a valid CAS Registry Number.

254878-95-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-fluoro-4-methylsulfonylbenzaldehyde

1.2 Other means of identification

Product number -
Other names 3-Fluoro-4-(methylsulphonyl)benzaldehyde

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:254878-95-0 SDS

254878-95-0Relevant articles and documents

PRODRUGS AND MEDICAL USES THEREOF

-

Paragraph 024, (2019/12/25)

The invention relates to nitrogen mustards bearing substituted piperazine carboxamide and their corresponding pharmaceutically acceptable salts as cytotoxic agents that target tumours and methods of use thereof, alone or in combination with other cancer t

PIPERIDINE DERIVATIVES USEFUL AS GPR119 AGONISTS

-

Page/Page column 33, (2013/05/21)

Substituted piperidine compounds and pharmaceutically acceptable salts thereof are disclosed. Pharmaceutical compositions and methods of treatment are also included. The present invention relates to G-protein coupled receptor agonists. In particular, the present invention is directed to agonists of GPR 119 that are useful for the treatment of diabetes, especially type 2 diabetes, obesity, the metabolic syndrome and related diseases and conditions.

Development of a practical route for the manufacture of N-[5-(3-lmidazol-1-yl-4-methanesulfonyl-phenyl)-4-methyl-thiazol-2-yl]acetamide

Hirt, Hans,Haenggi, Ruedi,Reyes, Jesus,Seeger-Weibel, Manuela,Gallou, Fabrice

, p. 111 - 115 (2012/12/31)

An efficient synthesis of a potent candidate in our respiratory program is described. The synthesis based on a key Darzens condensation-α,β- epoxide rearrangement circumvented the toxicity and safety issues encountered in the original synthesis route. Sub

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 254878-95-0